Vycor Medical 

$0.052400
6
+$0.00+0.77%Friday 20:00

Statistics

Day High
0.0524
Day Low
0.0524
52W High
0.2
52W Low
0.017
Volume
1,000
Avg. Volume
14,115
Mkt Cap
1.75M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0051

Financials

-21.31%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.86MRevenue
-397,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, competing with Vycor's neurosurgery and surgical access systems.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers a wide range of medical devices and technologies, including surgical solutions that compete with Vycor's offerings.
Smith & Nephew
SNN
Mkt Cap12.43B
Smith & Nephew specializes in surgical equipment, including minimally invasive surgery products, competing in the same space as Vycor.
Stryker
SYK
Mkt Cap111.95B
Stryker is a major player in medical technologies, including surgical equipment and neurotechnology, directly competing with Vycor's product lines.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. provides surgical solutions and orthopedic devices that can be seen as alternatives to Vycor's surgical access products.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation offers a broad range of medical devices that compete with Vycor's neurosurgery and healthcare products.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices segment, competes across a broad range of surgical and medical products, overlapping with Vycor's market.
Globus Medical
GMED
Mkt Cap10.48B
Globus Medical, Inc. focuses on musculoskeletal solutions, including spine surgery technologies that compete with Vycor's neurosurgical products.
Alphatec
ATEC
Mkt Cap1.08B
Alphatec Holdings, Inc. designs and develops spinal surgery products, directly competing with Vycor's focus on neurosurgery and surgical access solutions.

About

Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
Show More
CEO
Peter C. Zachariou
Employees
7
Country
United States
ISIN
US92921M2035

Listings

0 Comments

Share your thoughts

FAQs

What is Vycor Medical stock price today?▼
The current price of VYCO is $0.05 USD — it has increased by +0.77% in the past 24 hours. Watch Vycor Medical stock price performance more closely on the chart.
What is Vycor Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Vycor Medical stocks are traded under the ticker VYCO.
Is Vycor Medical stock price growing?▼
VYCO stock has risen by +49.71% compared to the previous week, the month change is a -20.61% fall, over the last year Vycor Medical has showed a -70.06% decrease.
What is Vycor Medical market cap?▼
Today Vycor Medical has the market capitalization of 1.75M
What were Vycor Medical earnings last quarter?▼
VYCO earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vycor Medical revenue for the last year?▼
Vycor Medical revenue for the last year amounts to 1.86M USD.
What is Vycor Medical net income for the last year?▼
VYCO net income for the last year is -397,000 USD.
How many employees does Vycor Medical have?▼
As of November 3, 2026, the company has 7 employees.
In which sector is Vycor Medical located?▼
Vycor Medical operates in the Health & Wellness sector.
When did Vycor Medical complete a stock split?▼
The last stock split for Vycor Medical was on January 15, 2013 with a ratio of 1:150.
Where is Vycor Medical headquartered?▼
Vycor Medical is headquartered in Boca Raton, United States.